It was founded by David Mitchell (who suffers from multiple myeloma), and has Merith Basey as its Executive Director since 2022.
It is financed by the Action Now Initiative (ANI) which is funded by the Laura and John Arnold Foundation.
[1] It is bipartisan and does not accept funding from any organizations that profit from development or distribution of prescription drugs.
[3] It spent about $10 million to highlight drug prices as an issue in the 2018 United States elections.
"[5] When Eli Lilly and Company announced a halving of the price of insulin lispro Wakana denounced the move as a "token PR play".